The term "N=411" appears in FDA multidiscipline reviews for dermatological treatments (like Trifarotene).
Providing more context (such as a field of study or where you saw the term) would help in providing a more targeted review. N(411)rar
: High RAR levels are often linked to increased inflammation and poor clinical outcomes. In a group of 411 subjects, researchers found that this specific ratio could effectively categorize patient risk. 2. Clinical Drug Trials The term "N=411" appears in FDA multidiscipline reviews
"N=411" is a common starting number for records identified in systematic reviews before screening. In a group of 411 subjects, researchers found
: A study with a sample of N=411 patients investigated RAR as a predictor for mortality in patients with acute kidney injury or other critical illnesses.
: These studies involve the Retinoic Acid Receptor (RAR) family (specifically RAR